LAG3-PD1

N/A

Report date: 2025/01/26 17:16:10

Base Information

Drug NameLAG3-PD1
Drug Alias Namedual LAG-3 checkpoint inhibitor/PD-1 checkpoint inhibitor (Shandong Fontacea Pharmaceutical)LAG3-PD1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionProgrammed cell death protein 1 blockersLymphocyte activation gene 3 protein inhibitors
TargetsLymphocyte activation gene 3 proteinProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Fontacea Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Fontacea Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A